Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesHot NewsMost Read NewsRecomm.Business LeadersCalendar 
The feature you requested does not exist. However, we suggest the following feature:

The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of KBR, Inc. Shareholders and a Lead Plaintiff Deadline of July 3, 2017

share with twitter share with LinkedIn share with facebook
share via e-mail
0
06/26/2017 | 05:25pm CEST

NEW YORK, June 26, 2017 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of KBR, Inc. (NYSE:KBR) who purchased shares between February 26, 2016 and April 27, 2017. The action, which was filed in the United States District Court for the Southern District of Texas, alleges that the Company violated federal securities laws.

In particular, the complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that (i) the Company’s United Kingdom (“UK”) subsidiaries had violated applicable bribery and corruption laws; and (ii) as a result of the foregoing, KBR’s public statements were materially false and misleading at all relevant times.

Shareholders have until July 3, 2017 to petition the court for lead plaintiff status. Your ability to share in any recovery does not require that you serve as lead plaintiff. You may choose to be an absent class member.

If you suffered a loss during the class period and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit http://www.kleinstocklaw.com/pslra-sa/kbr-inc?wire=3.

Joseph Klein, Esq. is an experienced attorney and has also practiced as a Certified Public Accountant. Mr. Klein represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Joseph Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

Primary Logo


© GlobeNewswire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news
Date Title
05:25p The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of KBR, Inc. Shareholders and a Lead Plaintiff Deadline of July 3, 2017
05:25p Monarca Minerals Inc. Announces Completion of Debt Settlement
05:25p ORLA MINING : Grants Incentive Stock Options and Bonus Shares
05:25p Global Emergency Alarm and Evacuation Systems Market 2017-2021 with Siemens, Honeywell International, Johnson Controls, Bosch & Hochiki Dominating - Research and Markets
05:24p PETROLEO BRASILEIRO PETROBRAS : We have approved an agreement with investors to settle an individual action in the US
05:24p ELLAKTOR : Consolidated Report on payments to governments, 26 June 2017
05:24p GOOD PEOPLE : Thursday event addresses human trafficking
05:24p HMS HYDRAULIC MACHINES & SYSTEM PCL : Group 2016 FY Dividends
05:24p STORM REAL ESTATE : Preliminary result of the rights offering
05:24p PANTHER SECURITIES : Results of AGM – June 2017
Latest news
Advertisement
Hot News 
-1.69%Kinnevik appoints Georgi Ganev as CEO
2.06%AP MOLLER MAERSK : Maersk Line plans pharma transport market push with new digital tool
1.21%In Unilever's Radical Hiring Experiment, Resumes Are Out, Algorithms Are In
1.14%Japanese airbag maker Takata files for bankruptcy, gets Chinese backing
0.68%EU must get more Russian guarantees over gas pipeline plan - Ukraine
Most Read News
10:39a U.S. activist presses for 'bold action' at Nestle
05:01a INSTINET : and Virtu Financial launch liquidity streaming relationship
07:13a MIKHAIL FRIDMAN : Fridman's L1 Retail to buy Holland & Barrett for $2.3 billion
10:04a Facebook in talks to produce original TV-quality shows - WSJ
09:18a RETROPHIN : 'Pharma bro' Martin Shkreli heads into fraud trial
Most recommended articles
11:22aDJSteel Yourself for Trump's Anti-Trade Moves
11:20aDJMARKET SNAPSHOT : Want To Know Where The Stock Market's Headed Over The Next 6 Months? Don't Ask OPEC
11:17aDJNEWS HIGHLIGHTS : Top Global Markets News of the Day
11:17aDJNEWS HIGHLIGHTS : Top Energy News of the Day
11:14a TSX down as softer commodity prices weigh on resource shares